Hmmm...interesting

Evaluation of Stroke Risk Following COVID-19 mRNA Bivalent Vaccines Among U.S. Adults Aged ≥65 Years | medRxiv
Favicon 
www.medrxiv.org

Evaluation of Stroke Risk Following COVID-19 mRNA Bivalent Vaccines Among U.S. Adults Aged ≥65 Years | medRxiv

medRxiv - The Preprint Server for Health Sciences